'Dergi'
/
Ormancılık ve botanik
/
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
JoVE Journal
Ormancılık ve botanik
This content is Free Access.
JoVE Journal Ormancılık ve botanik
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

DOI:
10.3791/50070-v

•

09:29 min

•

February 01, 2013

•

, , , , , , , ,
1Division of Pediatrics,U.T. MD Anderson Cancer Center, 2Department of Stem Cell Transplantation and Cellular Therapy,U.T. MD Anderson Cancer Center

'Bölümler'

  • 00:05'Başlık'
  • 02:09Isolation of Mononuclear Cells from PB and UCB
  • 03:04Preparation of T Cells for Electroporation
  • 04:03Electroporation of MNC
  • 05:59FACS Analysis of CAR Expression (Day 1)
  • 06:32Preparation of aAPC (Clone #4) on Day 1
  • 07:01aAPC-mediated Stimulation of CAR+ T Cells (Day 1)
  • 07:33Results: SB System Coupled with Co-culture on aAPC Generates CD19-specific CAR+ T Cells
  • 08:44Conclusion

Özet

'Otomatik Çeviri'

'Otomatik Çeviri'

T cells expressing a CD19-specific chimeric antigen receptor (CAR) are infused as investigational treatment of B-cell malignancies in our first-in-human gene therapy trials. We describe genetic modification of T cells using the Sleeping Beauty (SB) system to introduce CD19-specific CAR and selective propagation on designer CD19+ artificial antigen presenting cells.

'Etiketler'

Sleeping BeautyArtificial Antigen Presenting CellsGenetic ModificationT CellsPeripheral BloodUmbilical Cord BloodCAR T CellsCD19Gene TherapyImmunotherapyTumor-associated AntigensClinical Application

Article

Embed

'ÇALMA LİSTESİNE EKLE'

Usage Statistics

'İlgili Videolar'

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Generation of Human Alloantigen-specific T Cells from Peripheral Blood

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Read Article